It’s self apparent that the law is a part of everyone’s life. But I, like most people, tend to think of it on a very personal level. I consider how my actions would fit into the law. But I don’t often consider the underlying legal factors and deals which allow medications to get onto the market. Or where those profits will end up going. But a recent case involving Laidlaw & Company has made me far more aware of just how ubiquitous legal issues really are.
Laidlaw & Company recently received a temporary restraining order and associated injunction. The investment bank is currently settling legal matters between itself and a clinical-stage company by the name of Relmada Therapeutics. And the medical company is insistent that Laidlaw & Company has been spreading misleading information about them. It seems plausible enough for the court to begin acting on that concern even while proceedings are still in motion. The matter is further complicated by the fact that Laidlaw & Company had previously served as an investment banker to Relmada Therapeutics. As an outside observer, I found this entire situation fascinating and rather complex.
Looking into Laidlaw & Company helped to add a little extra context for me. To be sure, it’s still a complex case. But I was at least able to understand where Laidlaw & Company was coming from. The company’s principals, Matthew Eitner and James Ahern, are highly featured within the Laidlaw & Company site. I also found it quite interesting to see the company’s history, dating all the way back to 1846. To put things into the proper historical context, Lincoln was only just getting married when Laidlaw & Company were formed.
Laidlaw & Company strikes me as an investment bank which has a lot of momentum behind it. It’s easy for a company with such an extensive history to seem a bit overly harsh at times. But I also believe that any entity which has survived intact since 1846 will by necessity have some bluntness to its approach at times. If so, it’s a philosophy which seems to be working for it since they’re thriving in both the US and Europe.